{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:08:06Z","timestamp":1784171286718,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.cca.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T22:46:29Z","timestamp":1326494789000},"page":"719-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies"],"prefix":"10.1016","volume":"413","author":[{"given":"M.","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bentow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Sinico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2012.01.004_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.30286","article-title":"Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis","volume":"63","author":"Falk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2012.01.004_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/ar96","article-title":"What you should know about PR3-ANCA. An introduction","volume":"2","author":"Wiik","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cca.2012.01.004_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/rheumatology\/keh028","article-title":"Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study","volume":"43","author":"Csernok","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2012.01.004_bb0020","first-page":"295","article-title":"Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients","volume":"56","author":"Arranz","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cca.2012.01.004_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(97)00203-2","article-title":"Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA\/PR3 immunecomplexes","volume":"211","author":"Sun","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2012.01.004_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04649.x","article-title":"High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay","volume":"1173","author":"Roggenbuck","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2012.01.004_bb0035","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.2009.109868","article-title":"Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3","volume":"69","author":"Holle","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2012.01.004_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/B:JOCI.0000029115.79266.ae","article-title":"ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis","volume":"24","author":"Rutgers","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2012.01.004_bb0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.autrev.2008.07.033","article-title":"Performance of the BioPlex 2200 Autoimmune Vasculitis kit","volume":"8","author":"Kaul","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2012.01.004_bb0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1196\/annals.1398.051","article-title":"Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease","volume":"1109","author":"Damoiseaux","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2012.01.004_bb0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jim.2008.03.012","article-title":"Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD)","volume":"336","author":"Trevisin","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2012.01.004_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/ard.2007.086579","article-title":"A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis","volume":"68","author":"Damoiseaux","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2012.01.004_bb0065","first-page":"1027","article-title":"A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe","volume":"26","author":"Ito-Ihara","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2012.01.004_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1313.019","article-title":"Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis","volume":"1050","author":"Sinico","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2012.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2012.01.004_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR Project for ANCA Assay Standardization","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2012.01.004_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2012.01.004_bb0090","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2012.01.004_bb0095","first-page":"707","article-title":"Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives","volume":"18","author":"Radice","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2012.01.004_bb0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.2009.109868","article-title":"Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3","volume":"69","author":"Holle","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2012.01.004_bb0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/ard.2009.109868","article-title":"Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3","volume":"69","author":"Holle","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2012.01.004_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2005.09.004","article-title":"A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases","volume":"307","author":"Lee","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2012.01.004_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/00313020701230641","article-title":"Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA","volume":"39","author":"O'Donnell","year":"2007","journal-title":"Pathology"},{"key":"10.1016\/j.cca.2012.01.004_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cca.2008.07.026","article-title":"Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies","volume":"397","author":"Vermeersch","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2012.01.004_bb0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.2001.5200","article-title":"Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions","volume":"103","author":"Russell","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cca.2012.01.004_bb0130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/ndt\/12.9.1863","article-title":"Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes","volume":"12","author":"Westman","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2012.01.004_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2007.05.001","article-title":"AutoAbSC. Org \u2014 Autoantibody Standardization Committee in 2006","volume":"6","author":"Chan","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2012.01.004_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1196\/annals.1398.004","article-title":"Standardization of autoimmune diagnostics in Germany: activities of the German group in the European Autoimmune Standardization Initiative","volume":"1109","author":"Sack","year":"2007","journal-title":"Ann N Y Acad Sci"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T12:11:44Z","timestamp":1561205504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898112000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0009898112000101"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2012.01.004","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}